Floatz logo

Nivestim

Myeloproliferative Neoplasm

City of Hope Medical Centerprotein_peptidePhase 3Active
BB
69/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
63/ 100
Competitive Position
81/ 100

Competitive context

69 Active assets in the Myeloproliferative Neoplasm cohort.

Asset / SponsorPhaseRating
MELPHALAN
Center for International Blood and Marrow Transplant Research
Phase 2/3BBB
Fludarabine
Sawa Ito, MD
Phase 4BB
ANTI-HUMAN T-LYMPHOCYTE IMMUNOGLOBULIN, RABBIT
Fred Hutchinson Cancer Center
Phase 2/3BB
Romidepsin
Sawa Ito, MD
Phase 4BB
Carboplatin
OHSU Knight Cancer Institute
Phase 2/3BB

View all 50 →

Same molecule, other indications

Nivestim is also rated in:

Burkitt lymphomaActive
BBB
Indicative · Phase 4
78 / 100
View asset →
neutropeniaActive
BBB
Indicative · Phase 4
76 / 100
View asset →
mycosis fungoidesDormant
BBB
Indicative · Phase 4
75 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →